Literature DB >> 1122173

Hereditary mental depression and Parkinsonism with taurine deficiency.

T L Perry, P J Bratty, S Hansen, J Kennedy, N Urquhart, C L Dolman.   

Abstract

An unusual neuropsychiatric disorder inherited in autosomal dominant fashion occurred in three successive generations of a family. Symptoms commenced late in the fifth decade in six affected patients and led to death in four to six years. The earliest and most prominent symptom was mental depression not responsive to antidepressant drugs or electroconvulsive therapy. This was accompanied by exhaustion, sleep disturbances, and marked weight loss. Later in the disease, symptoms of parkinsonism appeared, and respiratory failure occured terminally. The most recently affected family member was investigated biochemically late in his illness. Concentrations of taurine were greatly diminished in plasma and cerebrospinal fluid, and at autopsy, all regions of brain examined had a markedly reduced taurine content. Since taurine is a putative inhibitory synaptic transmitter, deficiency of brain taurine may possibly have caused the psychiatric and neurological manifestations of this disorder.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122173     DOI: 10.1001/archneur.1975.00490440058009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  27 in total

1.  Latin America's first case of Perry syndrome and a new treatment option for respiratory insufficiency.

Authors:  Felipe Pretelt; Camilo Castañeda Cardona; Pawel Tacik; Owen A Ross; Zbigniew K Wszolek
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

Review 2.  DCTN1-related neurodegeneration: Perry syndrome and beyond.

Authors:  Takuya Konno; Owen A Ross; Hélio A G Teive; Jarosław Sławek; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-06-12       Impact factor: 4.891

3.  Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.

Authors:  Takayasu Mishima; Shunsuke Koga; Wen-Lang Lin; Koji Kasanuki; Monica Castanedes-Casey; Zbigniew K Wszolek; Shin J Oh; Yoshio Tsuboi; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

4.  Hypoventilation in a case of nonfamilial Parkinson's disease.

Authors:  R Y Darwish; R D Fairshter; N D Vaziri; J Rooney; G Schwartz
Journal:  West J Med       Date:  1985-09

5.  Muscle relaxation induced in the rabbit by intracerebroventricular taurine injection: a supraspinal effect.

Authors:  G P Sgaragli; M Magnani; V Carlà; A Giotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

6.  Respiration and sleep in Parkinson's disease.

Authors:  M C Apps; P C Sheaff; D A Ingram; C Kennard; D W Empey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

7.  Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls.

Authors:  B E Moen; K R Kyvik; B A Engelsen; T Riise
Journal:  Br J Ind Med       Date:  1990-04

8.  Elucidating the genetics and pathology of Perry syndrome.

Authors:  Christian Wider; Justus C Dachsel; Matthew J Farrer; Dennis W Dickson; Yoshio Tsuboi; Zbigniew K Wszolek
Journal:  J Neurol Sci       Date:  2009-09-04       Impact factor: 3.181

9.  A parkinsonian kindred.

Authors:  F Degl'Innocenti; M T Maurello; P Marini
Journal:  Ital J Neurol Sci       Date:  1989-06

10.  Pallidonigral TDP-43 pathology in Perry syndrome.

Authors:  Christian Wider; Dennis W Dickson; A Jon Stoessl; Yoshio Tsuboi; Françoise Chapon; Ludwig Gutmann; Bernard Lechevalier; Donald B Calne; David A Personett; Mary Hulihan; Jennifer Kachergus; Rosa Rademakers; Matthew C Baker; Linda L Grantier; O K Sujith; Laura Brown; Susan Calne; Matthew J Farrer; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2008-08-23       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.